Barratt, M. J., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review, 32(2), 141–146. https://doi.org/10.1111/dar.12005

Article  PubMed  Google Scholar 

Benschop, A., Urbán, R., Kapitány-Fövény, M., Van Hout, M. C., Dąbrowska, K., Felvinczi, K., Hearne, E., Henriques, S., Kaló, Z., Kamphausen, G., Silva, J. P., Wieczorek, Ł, Werse, B., Bujalski, M., Korf, D., & Demetrovics, Z. (2020). Why do people use new psychoactive substances? Development of a new measurement tool in six European countries. Journal of Psychopharmacology, 34(6), 600–611. https://doi.org/10.1177/0269881120904951

Article  PubMed  Google Scholar 

Bonar, E. E., Ashrafioun, L., & Ilgen, M. A. (2014). Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates. Drug and Alcohol Dependence, 143, 268–271. https://doi.org/10.1016/j.drugalcdep.2014.07.009

Article  PubMed  PubMed Central  Google Scholar 

Bresin, K., & Mekawi, Y. (2019). Do marijuana use motives matter? Meta-analytic associations with marijuana use frequency and problems. Addictive Behaviors, 99, 106102. https://doi.org/10.1016/j.addbeh.2019.106102

Article  PubMed  Google Scholar 

Cohen, K., & Weinstein, A. (2018). The effects of cannabinoids on executive functions: Evidence from cannabis and synthetic cannabinoids—A systematic review. Brain Sciences, 8(3), 40. https://doi.org/10.3390/brainsci8030040

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corazza, O., Demetrovics, Z., van den Brink, W., & Schifano, F. (2013b). “Legal highs”: An inappropriate term for “novel psychoactive drugs” in drug prevention and scientific debate. International Journal of Drug Policy, 24(1), 82–83. https://doi.org/10.1016/j.drugpo.2012.06.005

Article  PubMed  Google Scholar 

Corazza, O., Assi, S., Simonato, P., Corkery, J., Bersani, F. S., Demetrovics, Z., Stair, J., Fergus, S., Pezzolesi, C., Pasinetti, M., Deluca, P., Drummond, C., Davey, Z., Blaszko, U., Moskalewicz, J., Mervo, B., Furia, L. D., Farré, M., Flesland, L., … Schifano, F. (2013a). Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: The outcomes of the ReDNet project. Human Psychopharmacology: Clinical and Experimental, 28(4), 317–323. https://doi.org/10.1002/hup.2299

Csák, R., Szécsi, J., Kassai, S., Márványkövi, F., & Rácz, J. (2020). New psychoactive substance use as a survival strategy in rural marginalised communities in Hungary. International Journal of Drug Policy, 85, 102639. https://doi.org/10.1016/j.drugpo.2019.102639

Article  PubMed  Google Scholar 

Daikeler, J., Bošnjak, M., & Lozar Manfreda, K. (2020). Web versus other survey modes: An updated and extended meta-analysis comparing response rates. Journal of Survey Statistics and Methodology, 8(3), 513–539. https://doi.org/10.1093/jssam/smz008

Article  Google Scholar 

ESPAD Group. (2016). ESPAD Report 2015: Results from the European School Survey Project on Alcohol and Other Drugs. Publications Office of the European Union. https://www.espad.org/report/home

ESPAD Group. (2020). ESPAD Report 2019: Results from the European School Survey Project on Alcohol and Other Drugs. EMCDDA Joint Publications, Publications Office of the European Union. https://www.espad.org/espad-report-2019#downloadReport

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2021b). European Web Survey on Drugs 2021: Methodology. https://www.emcdda.europa.eu/publications/data-fact-sheets/european-web-survey-drugs-2021-methodology_en

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2021a). New psychoactive substances: Health and social responses. https://www.emcdda.europa.eu/publications/mini-guides/new-psychoactive-substances-health-and-social-responses_en

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2023a). European Drug Report 2023: Trends and developments. https://www.emcdda.europa.eu/publications/european-drug-report/2023_en

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2023b). Statistical Bulletin 2023: Latest data and statistics on the drug situation in Europe. https://www.emcdda.europa.eu/data/stats2023_en

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2023c). Spotlight on synthetic cannabinoids. https://www.emcdda.europa.eu/spotlights/synthetic-cannabinoids_en

Fox, C. L., Towe, S. L., Stephens, R. S., Walker, D. D., & Roffman, R. A. (2011). Motives for cannabis use in high-risk adolescent users. Psychology of Addictive Behaviors, 25(3), 492–500. https://doi.org/10.1037/a0024331

Article  PubMed  PubMed Central  Google Scholar 

Gex, K. S., Gückel, T., Wilson, J., Ladd, B. O., & Lee, C. M. (2024). Why people use cannabis and why it matters: A narrative review. Current Addiction Reports, 11, 1045–1054. https://doi.org/10.1007/s40429-024-00599-3

Article  Google Scholar 

Iseger, T. A., & Bossong, M. G. (2015). A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophrenia Research, 162(1–3), 153–161. https://doi.org/10.1016/j.schres.2015.01.033

Article  PubMed  Google Scholar 

Kettner, H., Mason, N. L., & Kuypers, K. P. C. (2019). Motives for classical and novel psychoactive substances use in psychedelic polydrug users. Contemporary Drug Problems, 46(3), 304–320. https://doi.org/10.1177/0091450919863899

Article  Google Scholar 

Lafaye, G., Karila, L., Blecha, L., & Benyamina, A. (2017). Cannabis, cannabinoids, and health. Dialogues in Clinical Neuroscience, 19(3), 309–316. https://doi.org/10.31887/DCNS.2017.19.3/glafaye

Article  PubMed  PubMed Central  Google Scholar 

Loeffler, G., Delaney, E., & Hann, M. (2016). International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids. Brain Research Bulletin, 126, 8–28. https://doi.org/10.1016/j.brainresbull.2016.04.013

Article  CAS  PubMed  Google Scholar 

López-Pelayo, H., Madero, S., Gremeaux, L., et al. (2024). Synthetic cannabinoids and cannabis: How the patterns of use differ: Results from the European Web Survey on Drugs. International Journal of Mental Health and Addiction, 22, 1128–1144. https://doi.org/10.1007/s11469-022-00919-6

Article  Google Scholar 

Manfreda, K. L., Bosnjak, M., Berzelak, J., Haas, I., & Vehovar, V. (2008). Web surveys versus other survey modes: A meta-analysis comparing response rates. International Journal of Market Research, 50(1), 79–104. https://doi.org/10.1177/14707853080500010

Article  Google Scholar 

Matias, J., Kalamara, E., Mathis, F., Skarupova, K., Noor, A., & Singleton, N. (2019). The use of multinational web surveys for comparative analysis: Lessons from the European Web Survey on Drugs. International Journal of Drug Policy, 73, 235–244. https://doi.org/10.1016/j.drugpo.2019.03.014

Article  PubMed  Google Scholar 

Matias, J. (2022). European Web Survey on Drugs: An overview of the project. Monitoring drug use in the digital age: Studies in web surveys. EMCDDA Insights. https://www.emcdda.europa.eu/publications/insights/web-surveys/european-web-survey-drugs-overview-project_en

Pulver, B., Fischmann, S., Gallegos, A., & Christie, R. (2023). EMCDDA framework and practical guidance for naming synthetic cannabinoids. Drug Testing and Analysis, 15(3), 255–276. https://doi.org/10.1002/dta.3403

Article  CAS  PubMed  Google Scholar 

Škařupová, K., Singleton, N., Matias, J., & Mravčík, V. (2019). Surveying drug consumption: Assessing reliability and validity of the European Web Survey on Drugs questionnaire. International Journal of Drug Policy, 73, 228–234. https://doi.org/10.1016/j.drugpo.2019.03.005

Article  PubMed  Google Scholar 

Smith, K. E., & Staton, M. (2019). Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs? Substance Abuse, 40(2), 160–169. https://doi.org/10.1080/08897077.2018.1528495

Article  PubMed  Google Scholar 

Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013). Spicing things up: Synthetic cannabinoids. Psychopharmacology (Berl), 228(4), 525–540. https://doi.org/10.1007/s00213-013-3188-4

Article  CAS  PubMed  Google Scholar 

van Amsterdam, J., Brunt, T., & van den Brink, W. (2015). The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. Journal of Psychopharmacology, 29(3), 254–263. https://doi.org/10.1177/0269881114565142

Article  CAS  PubMed  Google Scholar 

Wieczorek, Ł, Dąbrowska, K., & Bujalski, M. (2022). Motives for using new psychoactive substances in three groups of Polish users: Nightlife, marginalised, and active on the internet. Psychiatria Polska, 56(3), 453–470. https://doi.org/10.12740/PP/131971

Article  PubMed  Google Scholar 

Winstock, A. R., & Barratt, M. J. (2013). Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence, 131(1–2), 106–111. https://doi.org/10.1016/j.drugalcdep.2012.12.011

Article  CAS  PubMed  Google Scholar 

Wright, K. B. (2005). Researching internet-based populations: Advantages and disadvantages of online survey research, online questionnaire authoring software packages, and web survey services. Journal of Computer-Mediated Communication, 10(3). https://doi.org/10.1111/j.1083-6101.2005.tb00259.x

Wu, M. J., Zhao, K., & Fils-Aime, F. (2022). Response rates of online surveys in published research: A meta-analysis. Computers in Human Behavior Reports, 7, 100206. https://doi.org/10.1016/j.chbr.2022.100206

Article  Google Scholar